(Q40929764)

24 September 2017

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease (English)

1 reference

24 September 2017

1 reference

1 reference

10

Goetz CG

1 reference

24 September 2017

8

Mufson EJ

1 reference

24 September 2017

1

Kordower JH

1 reference

24 September 2017

Palfi S

2

1 reference

24 September 2017

Chen EY

3

1 reference

24 September 2017

Ma SY

4

1 reference

24 September 2017

Sendera T

5

1 reference

24 September 2017

Cochran EJ

6

1 reference

24 September 2017

Cochran EJ

7

1 reference

24 September 2017

Penn R

9

1 reference

24 September 2017

Comella CD

11

1 reference

24 September 2017

language of work or name

1 reference

1 September 1999

1 reference

24 September 2017

1 reference

24 September 2017

46

1 reference

24 September 2017

419-424

1 reference

24 September 2017

3

1 reference

Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Dopaminergic neurons protected from degeneration by GDNF gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199909%2946%3A3%3C419%3A%3AAID-ANA21%3E3.0.CO%3B2-Q

10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference